Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer

Atsuhiko Tada, Hiroshi Ueoka, Katsuyuki Kiura, Masahiro Tabata, Mitsuhiro Takemoto, Hiromichi Yamane, Junichiro Hiyama, Keisuke Aoe, Takuo Shibayama, Haruhito Kamei, Shin Kawahara, Shingo Harita, Toshio Sato, Makoto Kobayashi, Kenji Eguchi, Shunkichi Hiraki, Yoshio Hiraki, Mitsune Tanimoto

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Eighteen elderly patients aged 76 years or older with small cell lung cancer were treated with carboplatin (AUC = 4 mg/ml.min, i.v. day 1) and etoposide (70 mg/m2 i.v. day 1-3) and 17 patients were evaluable. The median age of the study population was 77 years (range: 76-81). Eight patients had limited disease (LD) and nine did extensive disease (ED). The overall response rate was 88% for LD patients and 67% for ED patients. Median survival time was 219 days for LD patients and 158 days for ED patients. Grade 3 and 4 leukopenia, neutropenia, thrombocytopenia and anemia occurred in 41%, 76%, 24% and 6% of patients, respectively. There was one treatment-related death due to pneumonitis.

Original languageEnglish
Pages (from-to)751-756
Number of pages6
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume29
Issue number5
Publication statusPublished - May 2002

    Fingerprint

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

Tada, A., Ueoka, H., Kiura, K., Tabata, M., Takemoto, M., Yamane, H., Hiyama, J., Aoe, K., Shibayama, T., Kamei, H., Kawahara, S., Harita, S., Sato, T., Kobayashi, M., Eguchi, K., Hiraki, S., Hiraki, Y., & Tanimoto, M. (2002). Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 29(5), 751-756.